Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy
Phase 3
Completed
- Conditions
- Laparoscopic Surgical Procedures
- Interventions
- Device: Aeroneb Pro Nezulizer, Aerogen, IrelandDrug: ropivacaine
- Registration Number
- NCT00433316
- Lead Sponsor
- Carmel Medical Center
- Brief Summary
In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecological laparoscopic surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
- Elective gynecologic laparoscopic surgery including unilateral or bilateral salpingo-oopherectomy or ovarian cystectomy.
- The patient is not participating in other medical study at present or in the last 30 days.
- The patient signed on an informed consent.
- Age 18 years and above.
- ASA (American Society of Anesthesiologists) physical status grade 1- 2.
Read More
Exclusion Criteria
- Allergy to Ropivacaine, other local anesthetics or other medications listed in the protocol.
- The patient is participating in other medical experiment at present or in the last 30 days.
- Acute Pelvic Inflammatory Disease.
- Coumadin or Aspirin treatment.
- ASA physical status grade 3-4.
- Age < 18 years.
- Significant arrythmias
- Analgesic treatment for chronic pain
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Aeroneb Pro Nezulizer, Aerogen, Ireland Receiving 10ml of saline study ropivacaine Receiving 10ml of 1% ropivacaine
- Primary Outcome Measures
Name Time Method VAS score early post-operative
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
the Carmel Medical Center Ambulatory Gynecoendoscopic Unit
🇮🇱Haifa, Israel